IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.

Saved in:
Bibliographic Details
Title: IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
Authors: Valvezan AJ; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., McNamara MC; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Miller SK; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Torrence ME; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Asara JM; Division of Signal Transduction, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Henske EP; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Manning BD; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Source: JCI insight [JCI Insight] 2020 Apr 09; Vol. 5 (7). Date of Electronic Publication: 2020 Apr 09.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32271165
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Valvezan+AJ%22">Valvezan AJ</searchLink>; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22McNamara+MC%22">McNamara MC</searchLink>; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Miller+SK%22">Miller SK</searchLink>; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Torrence+ME%22">Torrence ME</searchLink>; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Asara+JM%22">Asara JM</searchLink>; Division of Signal Transduction, Beth Israel Deaconess Medical Center, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Henske+EP%22">Henske EP</searchLink>; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Manning+BD%22">Manning BD</searchLink>; Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676073%22">JCI insight</searchLink> [JCI Insight] 2020 Apr 09; Vol. 5 (7). <i>Date of Electronic Publication: </i>2020 Apr 09.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676073 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2379-3708 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223793708%22">23793708 </searchLink><i>NLM ISO Abbreviation: </i>JCI Insight <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32271165
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1172/jci.insight.135071
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: IMPDH inhibitors for antitumor therapy in tuberous sclerosis complex.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Valvezan AJ
      – PersonEntity:
          Name:
            NameFull: McNamara MC
      – PersonEntity:
          Name:
            NameFull: Miller SK
      – PersonEntity:
          Name:
            NameFull: Torrence ME
      – PersonEntity:
          Name:
            NameFull: Asara JM
      – PersonEntity:
          Name:
            NameFull: Henske EP
      – PersonEntity:
          Name:
            NameFull: Manning BD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 04
              Text: 2020 Apr 09
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2379-3708
          Numbering:
            – Type: volume
              Value: 5
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JCI insight
              Type: main
ResultId 1